Linda, a real GLASSIA patient.

Real GLASSIA patient since 2011
Self-infuses at home

For your patients with severe ALPHA-1 antitrypsin
deficiency with clinically evident emphysema

With GLASSIA®, you can give your Alpha-1 patients* the
freedom to infuse
on their terms

House icon with a person inside depicting GLASSIA self-administration at home option.
At home
House icon with a patient and a nurse inside depicting GLASSIA infusion at home by nurse option.
At home
with nurse
Infusion center icon depicting GLASSIA infusion option in an infusion center.
At infusion
Clinic icon depicting GLASSIA infusion option in a clinic.
At clinic

You can offer your Alpha-1 patients a weekly infusion with the most options for administration settings, including self-administration at home. Together, you can decide what works best for them.

*Alpha-1 patients are defined as patients who have Alpha-1 antitrypsin deficiency (AATD).

If self-administration is deemed appropriate, ensure that the patient/caregiver receives detailed instructions and adequate training on how to administer in the home or other appropriate setting and has demonstrated the ability to independently administer GLASSIA.

Get your patients started on GLASSIA.

From information about Alpha-1 antitrypsin deficiency (AATD) to GLASSIA coverage for your patients, you will find what you need here.

Checklist inside of a circle.

Initiate GLASSIA treatment for your Alpha-1 patients.

Initiate treatment using the Start Form and follow the steps for getting your patient started with GLASSIA.

Notebook icon inside of a circle.

Resources to help you get your patients started on GLASSIA

Find a variety of resources, including our Dosage and Administration Guide and forms for your practice.

A patient sitting on the ground talking on the phone, with a Takeda Patient Support logo on the top right corner.

Welcome to
Takeda Patient Support

—support specialists your patient can count on

When you prescribe GLASSIA for your patient, Takeda Patient Support is here for them. Our support specialists can address your patient’s questions and concerns and help get them the information they need.

For onboarding, access, and reimbursement assistance, our services include:

  • Benefits investigation to help determine your patient’s insurance benefits and eligibility for certain services
  • Prior authorization (PA), reauthorization, and appeals information
  • Information about financial assistance options for your patient, if they're eligible

Our additional services include:

  • Specialty pharmacy (or site of care) triage and coordination
  • Takeda product infusion training for healthcare providers, as well as home treatment support and education for your patient
  • Arranging for a trained nursing professional to teach your patient or their caregiver how to infuse treatment at home, if requested by your office
  • Directing your patient to community support resources

What to know about AATD and how to treat it with GLASSIA

GLASSIA is clinically proven to help increase Alpha-1 levels.1

GLASSIA is a liquid augmentation therapy trusted by pulmonologists for over a decade to help increase Alpha-1 levels.

Underdiagnosis of Alpha-1 antitrypsin deficiency is common.2 Here’s why.

AATD can be difficult to diagnose because it causes lung disease that mimics other lung conditions. When should you test for it?

Email icon.

Stay connected. Stay informed.

Sign up for more information about GLASSIA.


  1. GLASSIA. Prescribing information. Takeda Pharmaceuticals U.S.A., Inc.; 2023.
  2. Campos MA, et al. Chest. 2005;128(3):1179-1186.